| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |